Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-24Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])
-
CLINICAL_TRIALS study record update · 2025-12-22Headache Calm: App-based Breathing Program for Migraine Relief
-
CLINICAL_TRIALS study record update · 2025-12-19A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
-
CLINICAL_TRIALS study record update · 2025-12-19Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-18The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
-
CLINICAL_TRIALS study record update · 2025-12-15The Ubrelvy and Qulipta Pregnancy Exposure Registry EMPRESS: An Observational, Prospective Study to Assess the Safety of Ubrelvy (Ubrogepant) and Qulipta (Atogepant) During Pregnancy
-
CLINICAL_TRIALS study record update · 2025-12-15Development and Evaluation of an AI-empowered Voice-interactive Chatbot for Migraine Management Among Hong Kong Women: a Randomized Crossover Trial
-
CLINICAL_TRIALS study record update · 2025-12-12Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine - A Prospective, Randomized, Open Label, Delayed-Start Study to Evaluate the Safety and Performance of the Walther System
-
CLINICAL_TRIALS study record update · 2025-12-08Safety and Efficacy of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Single-Site, Phase 2 Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-12-05The Efficacy of Xeomin as a Prophylactic Therapy for Migraine in Patients With Traumatic Brain Injuries (TBIs) Versus Anomalous Health Incidents (AHIs)
-
CLINICAL_TRIALS study record update · 2025-12-04Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of add-on Eptinezumab Treatment to Brief Educational Intervention for the Preventive Treatment of Migraine in Patients With Dual Diagnosis of Migraine and Medication Overuse Headache
-
CLINICAL_TRIALS study record update · 2025-12-04A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
-
CLINICAL_TRIALS study record update · 2025-12-04A Phase I, Randomized, Double-blind, Placebo-controlled, Single and Multiple Doses Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PRT-064040 Nasal Spray in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2025-12-03"Investigation of the Effects of Individually Tailored Physiotherapy Approaches on Pain, Fatigue, and Physical Function in Individuals With Migraine: A Randomized Controlled Trial"
-
CLINICAL_TRIALS study record update · 2025-12-02An Open-Label, Multiple-Dose Evaluation of the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor
-
CLINICAL_TRIALS study record update · 2025-11-28Investigation of Motor Evoked Potential and Cortical Silent Period in Migraine Patients
-
CLINICAL_TRIALS study record update · 2025-11-24Use of Facial Feature to Objectively Diagnose and Monitor Treatment of Light Sensitivity
-
CLINICAL_TRIALS study record update · 2025-11-20Real-world Experience of Patients Newly Started on Erenumab in the Gulf Region: a Longitudinal Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2025-11-18Prevention and Treatment of Episodic Migraine by Cabergoline Therapy (PROTECT). A Randomized, Placebo-controlled, Double-blind, Investigator-initiated Trial
-
CLINICAL_TRIALS study record update · 2025-11-12A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine With an Open-Label Extension
-
CLINICAL_TRIALS study record update · 2025-11-12Machine Learning Assessment Of Next-Day Migraine Likelihood Collected Via The Nerivio App
-
CLINICAL_TRIALS study record update · 2025-11-06Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study
-
CLINICAL_TRIALS study record update · 2025-11-04GENESIS: AIMOVIG® Pregnancy Exposure Registry